Structure containing wound treatment material

• US 8,066,169 B2
• Filed: 03/02/2010
• Issued: 11/29/2011
• Est. Priority Date: 10/18/2004
• Status: Active Grant

• Current Assignee: Covidien LP (Medtronic Plc)
• Original Assignee: Tyco Healthcare Group LP (Medtronic Plc)
• Inventors: Viola, Frank J.
• Primary Examiner(s): Rada; Rinaldi I.
• Assistant Examiner(s): Lopez; Michelle
• Application Number:
  US12/715,715
• Publication Number:
  US 20100155454A1
• Time in Patent Office: 637 Days
• Field of Search: 227/175.1, 227/178.1, 227/179.1, 227/19, 606/219
• US Class Current: 227/178.1
• CPC Class Codes: A61B 17/00491 Surgical glue applicators surgical adhesives A61L24/00; two-component delivery syringes A61M5/19
• CPC Class Codes: A61B 17/064 Surgical staples, i.e. penetrating the tissue
• CPC Class Codes: A61B 17/068 Surgical staplers , e.g. containing multiple staples or clampsstaplers containing only one staple A61B17/10; magazines or containers for staples A61B17/105; for performing anastomosis A61B17/115; staplers in general B25C5/00
• CPC Class Codes: A61B 17/07292 Reinforcements for staple line, e.g. pledgets
• CPC Class Codes: A61B 17/115 Staplers for performing anastomosis in a single operation
• CPC Class Codes: A61B 17/1155 Circular staplers comprising a plurality of staples
• CPC Class Codes: A61B 2017/00831 Material properties
• CPC Class Codes: A61B 2017/00884 enhancing wound closure
• CPC Class Codes: A61B 2017/00893 pharmaceutically effective
• CPC Class Codes: A61B 2017/07214 Stapler heads
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00

Abstract

According to an aspect of the present disclosure, an anvil assembly for a circular stapling apparatus, is disclosed. The anvil assembly includes an anvil head configured to support an anvil plate thereon; a shaft extending from the anvil head and configured to selectively engage a connection member of the circular stapling apparatus; an anvil plate operatively connected to the anvil head, the anvil plate defining a plurality of staple forming pockets therein; and a wound treatment material disposed in each staple forming pocket of the anvil plate. The wound treatment material is at least one of an adhesive, a sealant, a hemostat and a medicament.

Claims

1. A surgical stapling apparatus comprising:

a tubular body portion having a connection member;

a staple cartridge assembly operably supported on the tubular body portion, the staple cartridge assembly having a plurality of staple retaining slots and a surgical staple in each of the staple retaining slots;

an anvil head configured to support an anvil plate thereon, the anvil plate defining a plurality of staple forming pockets in registration with the staple retaining slots;

a shaft extending from the anvil head and configured to selectively engage the connection member of the tubular body portion;

a wound treatment material disposed within each of the plurality of staple retaining slots of the staple cartridge assembly and each of the plurality of staple forming pockets of the anvil plate, wherein the wound treatment material is at least one of an adhesive, a sealant, a hemostat and a medicament; and

a liner at least partially extending over the anvil plate to retain the wound treatment material within each of the plurality of staple forming pockets prior to a firing of the surgical stapling apparatus.

2. The surgical stapling apparatus according to claim 1, wherein the liner is fabricated from a bio-absorbable material.

3. The surgical stapling apparatus according to claim 1, wherein the liner is fabricated from a fluid impermeable material which is ruptured by staples of the surgical stapling apparatus.

4. The surgical stapling apparatus according to claim 1, wherein at least a portion of the liner remains in a patient'"'"'s body after use of the surgical stapling apparatus.

5. The surgical stapling apparatus according to claim 1, wherein the adhesive includes at least one of a protein derived, aldehyde-based adhesive material, and a cyanoacrylate-based material.

6. The surgical stapling apparatus according to claim 1, wherein the sealant material includes at least one of a fibrin sealant material, a collagen-based and synthetic polymer-based tissue sealant material, and synthetic polyethylene glycol-based, hydrogel sealant material.

7. The surgical stapling apparatus according to claim 1, wherein the hemostat material includes at least one of a fibrin-based material, a collagen-based material, an oxidized regenerated cellulose-based material, a gelatin-based material, and a fibrinogen-thrombin material.

8. The surgical stapling apparatus according to claim 1, wherein the medicament includes at least one of drugs, enzymes, growth factors, peptides, proteins, dyes, and diagnostic agents.

9. The surgical stapling apparatus according to claim 1, further comprising a liner overlying at least some of the plurality of staple retaining slots.